Tumor cells that express a fusion gene of Escherichia coli cytosine deaminase ( CD ) and herpes simplex virus type 1 thymidine kinase ( TK ) sequences activate and are subsequently killed by the nontoxic prodrugs 5 -fluorocytosine and ganciclovir. We have previously developed a recombinant adenovirus containing the CD -TK fusion gene controlled by the human inducible heat shock protein 70 promoter so that heat at 418C for 1 hour induces therapeutic gene expression. This adenovirus effectively transduces heat -inducible expression of the CD -TK gene into human prostate carcinoma cells. However, because a limited number of cells in a tumor can actually be infected, we created a replicating adenoviral vector to increase CD -TK gene expression. This vector is a replication -competent, E1B -attenuated adenoviral vector containing the hsp70 promoter ± driven CD -TK gene ( Ad.E1A( + )HS -CDTK ). When human prostate adenocarcinoma DU -145 cells ( mutant p53 ) were infected with the virus at a multiplicity of infection ( MOI ) of 1 or 10, the viral replication was detected within 2 days at both MOIs. Similar results were observed in human colorectal carcinoma CX -1 cells. When DU -145 cells were infected with the virus at an MOI of 10, incubated for 24 hours, heated at 418C for 4 hours, and then harvested 20 hours later, Western blot analysis demonstrated that this virus successfully produced viral E1A proteins and heat shock stimulated the CD -TK gene expression by 12.3 -fold. In addition, Ad.E1A( + )HS -CDTK effectively suppressed cell proliferation by viral cytopathic effect ). Unlike with a replication -incompetent virus ( Ad.HS -CDTK ), the cytopathic effect of the virus and cytotoxicity in the presence of the prodrugs were still observed even at low MOI ( MOI = 1.0 ). Cancer Gene Therapy ( 2001 ) 8, 397 ± 404
A lthough current adenoviral vector ± based gene therapy techniques have been shown to be potentially powerful therapeutic tools, several limitations still need to be overcome; these include (a ) tumor specificity and (b ) delivery problem. 1 Thus, it is necessary to develop a tumor-specific promoter that allows stringent and highlevel expression of the therapeutic gene in the tumor but not normal tissue. It is also necessary to develop a selectively replicating adenovirus to overcome this delivery problem.
One approach to overcome tumor specificity is using a stress -inducible promoter, which offers special advantages for localized high -level expression of the targeting gene in the tumor. Promoters from several stress -inducible proteins may be suitable for this purpose. For example, glucose deprivation, chronic anoxia, and acidic pH, known to persist in solid tumors with poor vascularization, induce several stress -inducible proteins such as glucose -regulated proteins ( GRPs ), 2, 3 oxygen -regulated proteins ( ORPs ), 4 ± 6 heat shock proteins ( HSPs ), 7 erythropoietin ( EPO ), 8 vascular endothelial growth factor ( VEGF ), 9 and basic fibroblast growth factor (bFGF ). 10 Several researchers have also demonstrated that the early response genes c -jun, Egr-1, gadd45, and c -fos are induced following exposure of mammalian cells to ionizing radiation. 11 ± 16 Our previous studies demonstrated that the 70 -kDa heat shock gene ( hsp70 ) promoter has strong regulatory control without constitutive activity. 17 The other approach to overcome delivery problem is using a preferentially replicating adenoviral vector. It has been demonstrated that mutant adenovirus, lacking E1B expression, could exhibit preferential replication in carcinoma cells that lack normal p53 expression. 18 Thus, we proposed to generate a replicationcompetent adenovirus, which contains a functional E1A, but not E1B, to enhance the efficacy of tumor-specific killing of prostate carcinoma cells. This viral vector system will be very useful for prostate cancer, because mutation or deletion of the p53 genes can be detected in approximately 50% of all advanced -stage prostate cancers. 19, 20 In the field of cancer gene therapy using viral vectors, it is very difficult, perhaps impossible, to introduce a foreign gene into all target cells. Therefore adjacent cell killing, the so-called bystander effect, caused by genetically modified cells provides therapeutic advantages for gene therapy against cancers. For this purpose, we selected two toxin genes, herpes simplex virus ±thymidine kinase ( HSV-TK ) and bacterial cytosine deaminase ( E. coli CD ) gene as the prototype for gene therapy. The work of Freeman et al 21 demonstrated the bystander killing of KBALB murine cells in vitro and in vivo by expressing the HSV-TK gene. Significant cell growth delay and tumor regression was observed when as few as 10% of cells expressed HSV-TK. Recent studies suggest that bystander cell death is mediated by either gap-junctional intercellular communication 22, 23 or apoptotic vesicles associated with phagocytosis. 21 Fick et al 22 reported that the phosphorylated ganciclovir (GCV ) may be transferred through gap junctions to HSV-TK ±negative cells. In contrast, Freeman et al 21 observed that apoptotic vesicles generated from the dying HSV-TK ±positive cells were phagocytized by nearby HSV-TK ±negative cells. Unlike HSV-TK /GCV, the CD /5 -fluorocytosine (5 -FC ) bystander effect does not require direct cell -to -cell contact because the molecule deemed responsible for the effect, 5-fluorouracil (5 -FU ), freely diffuses through cell membranes. 24 Huber et al 24 observed that the bystander killing of human colorectal carcinoma cells in vitro and in vivo occurred when as few as 2% of cells expressed E. coli CD. These results established a rational approach to achieve significant bystander killing, even after gene transfer to only a small fraction of tumor cells. In this study, we demonstrate that E1B -attenuated adenoviral vectors effectively replicate in DU -145 and CX -1 cells, which have the mutant p53 phenotype. The CD -TK gene expression was successfully under the control of the human inducible hsp70 promoter.
MATERIALS AND METHODS

Cell culture
Human prostatic carcinoma DU -145 cells or human colorectal carcinoma CX -1 cells were maintained in DMEM media or RPMI media, respectively, containing 10% fetal bovine serum ( FBS ). Cells were used to examine the cytotoxic effects of CD -TK transduction and prodrug exposure. Infections with various multiplicities of infection ( MOIs ) of recombinant adenovirus were performed in DMEM media supplemented with 5% heat -inactivated horse serum for 1 day. Drug exposure was performed by replacement of the viral inoculum with maintenance medium containing the prodrug( s) for 24 hours before plating for survival determination.
Recombinant adenoviral vector construction
A replication -incompetent adenoviral vector containing the hsp70 promoter ± driven CD -TK gene (Ad.HS -CDTK ) was constructed previously. 17 To construct a replicationcompetent, E1B -attenuated adenovirus containing the hsp70 promoter ±driven CD -TK gene ( Ad.E1A( + )HS -CDTK ), we used the Cre -Lox recombination system. In brief, a 2 -kb DNA fragment containing the adenovirus type 5 E1A and 19 -kDa E1B coding region sequence was obtained by polymerase chain reaction. 25 Complementary oligonucleotide amplimers (30 base primers ) representing sequences flanking the E1A and 19 -kDa E1B coding region of template plasmid, pXC1 (Microbix, Toronto, Canada ) and terminal EcoRV / SalI restriction sites were used to facilitate cloning. The gene was isolated by restriction digestion with EcoRV and SalI, and cloned into the PvuII and SalI sites of pAdlox. The hsp70 promoter / CD -TK gene cassette from pÁE1sp1A /HS -CDTK 17 was removed by restriction digestion with XhoI and SalI and cloned into the adenovirus shuttle vector pAdlox containing the E1A gene at the SalI site. The completed shuttle vector was then cotransfected (calcium phosphate transfection method) into CRE8 cells with É5 adenovirus DNA to obtain replication-competent, E1B -attenuated adenovirus by homologous recombination. Plaques were harvested and analyzed. Virus was purified by CsCl step gradient and titrated as described previously. 26 
Assay for cytopathic effect and viral replication
To assay the cytopathic effects (CPEs ), cells (5Â10 4 / well, 12 -well plate) were infected with either Ad.HS-CDTK or Ad.E1A( + )HS -CDTK at an MOI of 0.1, 1, or 10 in 1 mL of DMEM containing 5% horse serum for 1 day and then cultured in 10% FBS for 2 ±8 days. Cells were fixed and stained with 0.5% crystal violet. Cells were also observed on a Nikon upright microscope (Nikon Microphot -FXL, Tokyo, Japan ). Digital images were captured by a 3CCD color video camera ( Model DXC -930P, Sony, Tokyo, Japan ). To assay the viral replication, the packaged adenovirus DNA from the host nucleic acids was separated by lysing the cells in spermine -HCl, which precipitates the unpackaged nucleic acids. The viral DNA was digested with BsaBI and analyzed on an agarose gel.
Hyperthermic treatment
T-25 flasks were heated by total immersion in a circulating water bath maintained within 0.058C of the desired temperature.
Western blotting
Expression of CD -TK protein or E1A protein in adenovirus infected cells was detected using sodium dodecyl sulfate ± polyacrylamide gel electrophoresis ( SDS -PAGE ) gradient gels ( 10± 18% ) and immunoblotting, as described previously, 17 using a human HSV-1 TK monoclonal antibody ( #4C8 ) provided by Dr. W. C. Summers ( Yale University, New Haven, CT ) or an adenovirus 2 E1A monoclonal antibody (Calbiochem, La Jolla, CA ), respectively. Proteins were visualized using the nonradioactive enhanced chemiluminescence ( ECL ) detection system (Amersham, Arlington Heights, IL ) and Fuji x -ray film.
Cell survival
The effects of viral vector ( Ad.HS -CDTK or Ad.E1A ( + )HS -CDTK ) infection, drug exposure, and hyperthermia on DU -145 or CX -1 cells were quantitated using clonogenic survival assays as previously described. 17 Cells were exposed to virus at an MOI of 1 plaque -forming unit ( pfu ) per cell. GCV and 5-FC were used at a concentration of 10 and 100 g/mL, respectively. Survival data was obtained from three independent experiments, and survival LEE, GALOFORO, BATTLE, ET AL: REPLICATING VIRAL VECTOR AND HEAT-INDUCIBLE DOUBLE SUICIDE GENE data was normalized for plating efficiency, hyperthermia, and virus effects.
RESULTS
Characterization of replicating adenoviral vectors
A replication -competent, E1B -attenuated adenoviral vector containing the hsp70 promoter ±driven CD -TK gene ( Ad.E1A( + )HS -CDTK ) was constructed as described in the Materials and Methods section. To confirm whether this virus could replicate in tumor cells lacking functional p53, DU -145 and CX -1 cells, which express a mutated p53, were infected with Ad.E1A( + )HS -CDTK or a replication-incompetent adenovirus (Ad.HS -CDTK ) at an MOI of 1 or 10. The infected cells were incubated for 1 or 2 days and then harvested. The packaged adenovirus DNA from the host nucleic acids was separated by lysing the cells in spermine -HCl, which precipitates the unpackaged nucleic acids. The viral DNA was digested with BsaBI and analyzed on an agarose gel. Figure 2 demonstrates that almost complete cytolysis was observed at an MOI of 1, and 10 in Ad.E1A( + )HS -CDTK ±infected cells. However, no significant CPE was seen at an MOI of 0.1. No significant CPE was observed at an MOI of 0.1, and 1 in Ad.HS -CDTK ±infected cells. Cytolysis was somewhat evident at higher titer (MOI= 10 ) in Ad.HS-CDTK ± infected cells. The prominent viral CPE was also observed in CX -1 cells infected with Ad.E1A( + )HS -CDTK but not with Ad.HS -CDTK at an MOI of 10 ( Fig 3 ) .
To determine the effect of Ad.E1A( + )HS -CDTK on cell proliferation, DU -145 cells were infected with either Ad.E1A( + )HS -CDTK or Ad.HS -CDTK at an MOI of 1 or 10. Figure 4 shows that Ad.E1A( + )HS -CDTK effectively suppressed cell proliferation. The suppression of cell proliferation was due to viral CPE ( Fig 2) , the cell number being reduced by 10-fold when viral titers were increased 10 -fold (MOI from 1 to 10 ).
Expression of CD -TK gene by heat shock
The Ad.E1A( + )HS -CDTK was further characterized by examining E1A gene expression and heat shock response in DU -145 cells. Cells were infected with virus at an MOI of 10 and incubated for 24 hours. After incubation, cells were heated at 418C for 4 hours and harvested 20 hours later. Expression of E1A and CD -TK gene was examined by Western blotting. Figure 5 clearly demonstrates that this virus produced E1A proteins and heat shock stimulated the
CD -TK gene expression by 12.3 -fold. Similar results were observed in CX -1 cells ( data not shown ).
We further examined the efficiency of Ad.E1A( + )HS -CDTK adenoviral vectors by determining the CD -TK gene expression at low MOI ( 0.01± 1 ) (Fig 6) . DU -145 cells were exposed to either Ad.HS -CDTK or Ad.E1A( + )HS -CDTK for 24 hours, followed by heat shock at 418C for 1 hour. The infected cells were harvested 19 hours after heat shock and CD -TK gene expression was determined by Western blot analysis. Figure 6 shows that the CD -TK protein was not detected in Ad.HS -CDTK infected cells. These results were consistent with previous observations. 17 Heat -inducible expression of CD -TK protein is detected at MOIs of 10 pfu /cell and greater in Ad.HS -CDTK ± infected cells. 17 In contrast, the CD -TK protein was detected in Ad.E1A( + )HS -CDTK virus ± infected cells at an MOI 0.1 and 1. Expression of the CD -TK protein was increased by increasing MOI or heat shock treatment.
Effect of virus and prodrug exposure on cell survival
To evaluate if heat -induced expression of CD -TK could activate the cytotoxic activity of the prodrugs GCVand 5 -FC, DU -145 cells were infected with viral vectors, heated, and then exposed to the prodrugs. Figure 7 shows that little or no cytotoxicity was observed for Ad.HS -CDTK ±infected ( MOI =1 ) cells in the presence of the prodrugs. In contrast, significant cytotoxicity was observed in Ad.E1A( + )HS -CDTK ±infected ( MOI = 1 ) cells. Ad.E1A( + )HS -CDTK alone or heat treatment alone reduced survival by 92.4 1.3% or 16.8 7.2%, respectively ( data not shown ). Survival was reduced by 72-, 15-, and 152-fold in the presence of 100 g /mL 5-FC, 10 g /mL GCV, and 100 g/ mL 5 -FC + 10 g /mL GCV, respectively, in Ad.E1A( + )HS -CDTK ±infected cells ( Fig 7 ) . Similar results were observed in CX -1 cells ( Fig 8 ) . Little cytotoxicity was observed for Ad.HS-CDTK ± infected ( MOI = 1 ) cells in the presence of 
DISCUSSION
Our studies demonstrated that we successfully constructed a viral vector that contains a suicide gene such as E. coli CD and herpes simplex virus type -1 TK fusion gene 27 under tight control of hsp70 promoter. The gene product is induced in tumor cells by treatment with heat shock. These viruses can also reproduce within human prostate tumor cells lacking functional p53. The CD -TK gene product activates normally innocuous prodrugs 5 -FC and GCV and subsequently generates cytotoxicity.
Inactivation of the tumor suppressor gene function is a critical step in the development of human neoplasia. The retinoblastoma and p53 tumor suppressor genes are inactivated or mutated in approximately 20 ±50% of advancedstage prostate carcinoma.
19,28 ± 31 Wild -type adenovirus infection of normal tissue requires the function of the viral protein E1A or E1B to inactivate retinoblastoma or p53, respectively, to prolong the cell survival and allow for viral replication. 18, 32 Therefore, mutant adenovirus lacking E1A or E1B, which can replicate within prostate tumor, will be useful to cancer gene therapy 18, 25, 33 and also offer an advantage to cope with intratumoral heterogeneity. 34 In this study, we confirmed this observation in human prostatic carcinoma DU -145 and human colorectal carcinoma CX -1 cells ( Fig 1A and B ) . However, the specificity of this effect for p53 has been questioned in certain types of cell lines. 35 ± 37 Recent studies showed that an E1B gene ±attenuated adenovirus has an apparent p53-dependent CPE at low MOIs. 38 This specificity is diminished at high MOIs. Similar results were observed in Figure 2 . In contrast to the replication -incompetent Ad.HS -CDTK, the viral CPE of the E1B -attenuated Ad.E1A( + )HS -CDTK was quite prominent at an MOI of 1. At high MOI, Ad.HS -CDTK also showed a CPE as well as inhibited cell proliferation ( Figs 2  and 4) . The effect of p53 status on the replication properties of the E1B -attenuated virus was also confirmed in isogenic cell lines that differ only in their p53 status. 39 The virus replicates more effectively in a subclone that expresses an inactivating mutant of p53. 39 This selectivity provides a means to control viral spread and to effectively destroy mutant p53 tumor cells in vivo. 39, 40 In this study, we also demonstrate that the E1B -attenuated virus effectively amplifies the therapeutic gene CD -TK expression through viral replication (Fig 6 ) .
We previously demonstrated that a 400-bp fragment of the inducible human hsp70B gene heat shock promoter has strong regulatory control without constitutive activity. 17 However, Figure 5 shows that there was some CD -TK production without heat shock in Ad.E1A( + )HS -CDTK ± infected cells. This is probably due to the replication of virus. 41 Although the leakage of the E1B -attenuated viral vector is considered to be a detriment to this viral vector system, the leakage may be beneficial in gene therapy. The virus would replicate preferentially in tumor cells lacking normal p53 expression and would produce the CD -TK without heat shock.
The use of HSV I-TK /GCV and E. coli CD /5-FC 42, 43 gene therapy systems have been characterized previously.
More recently, Rogulski et al 27 have described the construction of a fusion construct of the CD and TK genes, and have shown that transduction of this gene by retroviral vector can induce cytotoxicity and radiosensitization in the presence of 5 -FC and GCV in rat 9L gliosarcoma cells. In these studies, we demonstrated that expression of the CD -TK protein was dependent on the viral vector system and the MOI used to infect DU -145 cells (Fig 6) and CX -1 cells ( data not shown ). It is important to note that the CD -TK protein was detected in cells infected with Ad.E1A( + )HS -CDTK at as little as 0.1 ±1.0 pfu /cell. The cytotoxic effect of CD -TK expression at an MOI= 1.0 of Ad.E1A( + )HS -CDTK is approximately equivalent to that of an MOI of 20 of Ad.HS -CDTK ( Fig 7 and Ref. 17 ). This low MOI effect is clinically very important, because the amount and distribution of virus inoculum that can be delivered to the tumor may be limited. Moreover, the activated drugs can inhibit viral replication, which would control viral spread later on. 25 Although immune response to the viral infection is considered to be a major detriment to adenoviral gene therapy systems, 44 immune response may prove to be beneficial in this replicating viral system. The virus would be cleared by the immune system after induction of the anticancer activity has been completed. This effect may subsequently reduce the risk of recombinatory events. Nonetheless, recent clinical data demonstrated that there is no correlation between humoral immune responses and efficacy of treatment with ONYX -015, a replicating virus in patients with recurrent squamous cell cancer of head and neck. 40 In addition, there is no viral replication or associated necrosis in normal tissue. These results imply that the Ad.E1A( + )HS -CDTK will be also useful for clinical gene therapy.
